long term side effects of glp 1 drugs Glucagon-like Receptor-1 agonists for obesity: Weight loss outcomes, tolerability, effects, and risks 🎙️New Podcast Episode GLP-1 drugs

Molecules and Cells, 42 (12), 821827

The focus shifts from rapid change to optimization, body recomposition, and building the foundation for lasting results

The Food and Drug Administration (FDA) has approved it to promote weight loss in adults with obesity or in adults who are overweight with a weight-related health condition

SM, sphingomyelin

This process is vital for cellular respiration, where cells convert fats into energy to maintain optimal energy production

We did not include unstressed WKY rats or stressed Wistar controls, which would help disentangle strain-related from stress-induced neurobiological differences and clarify whether the observed alterations are specific to the treatment-resistant phenotype